Mitoxantrone Shows In Vitro, but Not In Vivo Antiviral Activity against Human Respiratory Syncytial Virus
Human respiratory syncytial virus (HRSV) is the most common cause of severe respiratory infections in infants and young children, often leading to hospitalization. In addition, this virus poses a serious health risk in immunocompromised individuals and the elderly. HRSV is also a major nosocomial ha...
Main Authors: | Patricia G. de la Sota, Elena Lorente, Laura Notario, Carmen Mir, Oscar Zaragoza, Daniel López |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/9/9/1176 |
Similar Items
-
A safe and efficient BCG vectored vaccine to prevent the disease caused by the human Respiratory Syncytial Virus
by: Emma Rey-Jurado, et al.
Published: (2017-09-01) -
Human Respiratory Syncytial Virus Infection in a Human T Cell Line Is Hampered at Multiple Steps
by: Ricardo de Souza Cardoso, et al.
Published: (2021-02-01) -
Human Respiratory Syncytial Virus Epidemiological Burden in Pediatric Outpatients in Italy: A Systematic Review
by: Sara Boccalini, et al.
Published: (2023-09-01) -
Cytokines in the Respiratory Airway as Biomarkers of Severity and Prognosis for Respiratory Syncytial Virus Infection: An Update
by: Yaneisi Vázquez, et al.
Published: (2019-06-01) -
In silico analysis of amino acid variation in human respiratory syncytial virus: insights into immunodiagnostics
by: Claudemir Souza, et al.